After bone cancer treatment left Kelly infertile, she needed IVF to realise her dream of being a mum. Now Kelly’s biggest wish is that her little girl will never have to experience the pain and lasting impact of cancer treatment.
Kelly faithfully kept a record of everything that happened after the initial diagnosis, chronicling the details of her story in a cancer scrapbook.
A/Prof Hawkins (fourth from left) and her research team at La Trobe University.
Osteosarcoma is the most common type of primary bone cancer. It mainly affects children and teens, and current treatments can leave survivors, like Kelly, with lifelong side effects.
A new class of anti-cancer agents known as “SMAC mimetics” are being tested on osteosarcoma cells. Early tests have shown that it can be effective in causing the cancer cells to die.
Your support can help cancer research like this reach clinical trials sooner, where real breakthroughs can be made.
Donate to cancer research this Christmas. Help make Kelly's wish for better treatments come true.